Defining Visual Impairment and Clinically Relevant Endpoints in Intermediate AMD: The MACUSTAR Project

Time: 10:00 am
day: Day Two


  • Identify hurdles for clinical development in intermediate AMD
  • Learn about MACUSTAR, an IMI (Innovative Medicines Initiative) project aiming to characterize visual functional deficits, structural changes and longitudinal progression in early and intermediate AMD
  • Discuss the industry perspective on the MACUSTAR project and its potential to support regulatory evaluations and patient access in intermediate AMD